Japanese Stock News

TSE:8306
TSE:8306Banks

Mitsubishi UFJ Financial Group (TSE:8306) Valuation Check After Reaffirmed Profit And Dividend Targets

Mitsubishi UFJ Financial Group (TSE:8306) has drawn fresh attention after an interim audit review left its nine month Japanese GAAP results unchanged, while management reaffirmed a ¥2.1t full year profit target and a ¥74 per share dividend. See our latest analysis for Mitsubishi UFJ Financial Group. The earnings confirmation and guidance reiteration come after a strong run in the shares, with the 90 day share price return of 22.52% and a 1 year total shareholder return of 59.67% pointing to...
TSE:8113
TSE:8113Household Products

What Unicharm (TSE:8113)'s Buyback After Guidance Cut Means For Shareholders

On February 12, 2026, Unicharm Corporation’s board approved a share repurchase program of up to 30,000,000 shares, or 1.72% of its capital, for ¥19,000 million running through December 17, 2026, following a prior downward revision of its 2025 earnings guidance due to weaker performance in China and Indonesia and impairment charges in Asia and India. This sequence of a profit warning and a sizeable buyback authorization highlights management’s focus on shareholder returns while addressing...
TSE:3088
TSE:3088Consumer Retailing

How Leadership Overhaul and 2026 Earnings Guidance Will Impact MatsukiyoCocokara (TSE:3088) Investors

MatsukiyoCocokara recently issued earnings guidance for the year ending March 31, 2026, forecasting net sales of ¥1.10 trillion, operating profit of ¥85.50 billion, profit attributable to owners of parent of ¥56.50 billion and basic earnings per share of ¥141.67, alongside board-approved changes to representative directors and other senior roles effective April 1, 2026. By pairing a comprehensive leadership reshuffle with quantified profit and dividend confidence, the company is signaling an...
TSE:2587
TSE:2587Beverage

Suntory Beverage And Food TSE 2587 Net Margin Slippage Tests Bullish Valuation Narrative

Latest FY 2025 Results Set the Stage for Suntory Beverage & Food Suntory Beverage & Food (TSE:2587) has just released its FY 2025 numbers, with fourth quarter revenue of ¥437.4 billion and basic EPS of ¥43.23, alongside trailing twelve month EPS of ¥287.13 on revenue of ¥1.72 trillion. Over recent periods, revenue has moved from ¥419.1 billion and EPS of ¥33.12 in Q4 2024 to ¥471.7 billion and EPS of ¥110.77 in Q3 2025, before settling at the latest Q4 levels. This gives investors a fresh...
TSE:5711
TSE:5711Metals and Mining

Mitsubishi Materials (TSE:5711) Q3 EPS Surge Tests High P/E Bullish Narratives

Mitsubishi Materials (TSE:5711) Q3 2026 earnings snapshot Mitsubishi Materials (TSE:5711) has reported Q3 2026 revenue of ¥454.6b and basic EPS of ¥236.47, backed by net income of ¥30.9b for the quarter. The company’s revenue moved from ¥494.1b in Q3 2025 to ¥454.6b in Q3 2026, while quarterly EPS shifted from ¥187.54 to ¥236.47 over the same period, against a trailing twelve month EPS of ¥162.93 on revenue of ¥1.76t. This combination of a softer top line and firmer per share earnings focuses...
TSE:1605
TSE:1605Oil and Gas

Inpex (TSE:1605) Margin Resilience Challenges Bearish Earnings Decline Narrative

Inpex (TSE:1605) has just wrapped up FY 2025 with fourth quarter revenue of ¥490,704 million and basic EPS of ¥86.17, while trailing twelve month figures sit at ¥2.0 trillion in revenue and EPS of ¥337.94, giving investors a clear view of both the latest quarter and the full year run rate. Over recent periods, revenue has moved from ¥518,280 million and EPS of ¥115.17 in Q4 2024 to ¥490,704 million and EPS of ¥86.17 in Q4 2025, with trailing net profit margin at 19.6% compared with 18.9% a...
TSE:4506
TSE:4506Pharmaceuticals

Assessing Sumitomo Pharma (TSE:4506) Valuation As AMCHEPRY Faces Key Parkinson’s Disease Review

Sumitomo Pharma (TSE:4506) is back on investors’ radar after Japan’s Ministry of Health, Labour and Welfare scheduled a February 19 committee review of AMCHEPRY, its allogeneic iPS cell derived therapy for advanced Parkinson’s disease. See our latest analysis for Sumitomo Pharma. The upcoming AMCHEPRY review arrives after a volatile few months, with a 10.81% 7 day share price return and a 14.19% 30 day share price decline. At the same time, a very large 1 year total shareholder return of...
TSE:7201
TSE:7201Auto

Nissan Motor (TSE:7201) Is Up 7.3% After Sharply Cutting Its 2026 Operating Loss Forecast

Nissan Motor recently revised its earnings guidance for the fiscal year ending March 31, 2026, now expecting net sales of ¥11,900,000 million, an operating loss of ¥60,000 million and a net loss of ¥650,000 million, largely reflecting faster fixed cost cuts under its Re:Nissan plan and lower foreign exchange headwinds. Although the projected net loss remains very large and is driven mainly by non‑cash restructuring and alignment charges, the sharply reduced operating loss forecast points to...
TSE:9984
TSE:9984Wireless Telecom

SoftBank Group (TSE:9984) Valuation Check After Recent Share Price Swings

SoftBank Group shares move after recent performance SoftBank Group (TSE:9984) has drawn fresh attention after a mixed stretch, with a roughly 10% gain over the past week, a modest rise over the past month, and a decline over the past 3 months. See our latest analysis for SoftBank Group. At around ¥4,390 per share, SoftBank Group’s recent 1 day share price return of about 9% decline contrasts with a weaker 90 day share price return and a much stronger 1 year total shareholder return. This...